Lexicon Pharmaceuticals (NASDAQ:LXRX) PT Raised to $8.00

Lexicon Pharmaceuticals (NASDAQ:LXRX – Get Rating) had its target price upped by equities researchers at Citigroup from $6.00 to $8.00 in a note issued to investors on Wednesday, The Fly reports. Citigroup’s price objective would suggest a potential upside of 195.20% from the stock’s current price. A number of other brokerages also recently issued reports […]

Related Keywords

,Citigroup ,Lexicon Pharmaceuticals Inc ,Manufacturers Life Insurance Company ,News Ratings For Lexicon Pharmaceuticals Daily ,Virtu Financial ,Institutional Trading Of Lexicon Pharmaceuticals ,Lexicon Pharmaceuticals ,Lexicon Pharmaceuticals Trading Down ,Jefferies Financial Group ,Great West Life Assurance Co ,Get Rating ,Financial Group ,Pharmaceuticals Trading Down ,West Life Assurance ,Lexicon Pharmaceuticals Daily ,Nasdaq Lxrx ,Lxrx ,Medical ,52887210 ,Boost Price Target ,Citigroup Inc ,